Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Vivoryon Therapeutics NV banner

Vivoryon Therapeutics NV
XETRA:05Y

Watchlist Manager
Vivoryon Therapeutics NV Logo
Vivoryon Therapeutics NV
XETRA:05Y
Watchlist
Price: 8.92 EUR 0.22% Market Closed
Market Cap: €196.7m
Write Note Create Alert Ask AI

Wall St Price Targets

05Y Price Targets Summary
Vivoryon Therapeutics NV

Wall Street analysts forecast 05Y stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 05Y is 39.92 EUR with a low forecast of 35.19 EUR and a high forecast of 50.12 EUR.

05Y Lowest Forecast
35.19 EUR
295% Upside
05Y Average Forecast
39.92 EUR
348% Upside
05Y Highest Forecast
50.12 EUR
462% Upside
Lowest Forecast
Price Target
35.19 EUR
295% Upside
Average Forecast
Price Target
39.92 EUR
348% Upside
Highest Forecast
Price Target
50.12 EUR
462% Upside
Vivoryon Therapeutics NV Competitors:
Price Targets
SUPN
Supernus Pharmaceuticals Inc
36% Upside
SUPN
Supernus Pharmaceuticals Inc
36% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

What are analyst estimates?

Continue 05Y Research

Summary
05Y intrinsic value, competitors valuation, and company profile.
DCF Valuation
05Y stock valuation using Discount Cash Flow valuation method.
Relative Valuation
05Y stock valuation using valuation multiples.
Wall St Estimates
05Y price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
05Y stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Vivoryon Therapeutics NV listings:
AEX • EUR
VVY
 F • EUR
05Y
 LSE • EUR
0R3M
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 05Y's stock price target?
Price Target
39.92 EUR

According to Wall Street analysts, the average 1-year price target for 05Y is 39.92 EUR with a low forecast of 35.19 EUR and a high forecast of 50.12 EUR.

Back to Top
ALPHA SPREAD
Follow us
Join 347,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett